T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
United Parks & Resorts
PRKS
$2.04B
| $11.4M | ﹤0.01% |
242,595
+1,290
| +0.5% | +$57.6K |
|
|
BBOT
1077
BridgeBio Oncology
BBOT
$726M
| $11.4M | ﹤0.01% |
1,071,550
| – | – |
|
|
PARA
1078
DELISTED
Paramount Global Class B
PARA
| $11.4M | ﹤0.01% |
881,325
-15,623
| -2% | -$183K |
|
1079
Match Group
MTCH
$8.71B
| $11.3M | ﹤0.01% |
365,982
-2,496
| -0.7% | -$74.7K |
|
1080
Charles River Laboratories
CRL
$13.4B
| $11.3M | ﹤0.01% |
74,470
-1,498
| -2% | -$200K |
|
1081
MGM Resorts International
MGM
$11.1B
| $11.2M | ﹤0.01% |
327,060
-17,350
| -5% | -$550K |
|
1082
WillScot Mobile Mini Holdings
WSC
$4.31B
| $11.2M | ﹤0.01% |
406,916
-2,643,135
| -87% | -$70.4M |
|
1083
Glaukos
GKOS
$10.9B
| $11.1M | ﹤0.01% |
107,542
+69,777
| +185% | +$6.55M |
|
1084
Fidelity National Financial
FNF
$13.3B
| $11.1M | ﹤0.01% |
197,612
+7,591
| +4% | +$444K |
|
1085
Seadrill
SDRL
$3B
| $11M | ﹤0.01% |
419,261
+14,876
| +4% | +$351K |
|
1086
Lyft
LYFT
$6.62B
| $10.8M | ﹤0.01% |
685,750
-183,919
| -21% | -$2.58M |
|
1087
Corcept Therapeutics
CORT
$12.4B
| $10.8M | ﹤0.01% |
147,092
+82,200
| +127% | +$5.96M |
|
1088
AES
AES
$10.5B
| $10.8M | ﹤0.01% |
1,025,775
-19,791
| -2% | -$212K |
|
1089
AngloGold Ashanti
AU
$48.7B
| $10.8M | ﹤0.01% |
236,165
+188,156
| +392% | +$8.1M |
|
1090
Graco
GGG
$13.3B
| $10.7M | ﹤0.01% |
124,567
+3,106
| +3% | +$257K |
|
1091
Franklin Resources
BEN
$17.2B
| $10.7M | ﹤0.01% |
448,535
-134
| -0% | -$2.76K |
|
1092
Enliven Therapeutics
ELVN
$4.31B
| $10.6M | ﹤0.01% |
528,250
+512,090
| +3,169% | +$9.69M |
|
1093
Albemarle
ALB
$16.1B
| $10.4M | ﹤0.01% |
165,525
+366
| +0.2% | +$21.6K |
|
1094
Chemed
CHE
$6.96B
| $10.3M | ﹤0.01% |
21,241
-1,583
| -7% | -$902K |
|
1095
KBR
KBR
$4.84B
| $10.3M | ﹤0.01% |
215,280
-2,514
| -1% | -$130K |
|
1096
Joby Aviation
JOBY
$7.83B
| $10.3M | ﹤0.01% |
972,373
+605,182
| +165% | +$4.38M |
|
|
BCYC
1097
Bicycle Therapeutics
BCYC
$273M
| $10.2M | ﹤0.01% |
1,468,393
-68,191
| -4% | -$543K |
|
1098
Fulton Financial
FULT
$4.72B
| $10.2M | ﹤0.01% |
563,776
+53,121
| +10% | +$907K |
|
1099
TD Synnex
SNX
$20.7B
| $10.2M | ﹤0.01% |
74,870
+3,113
| +4% | +$366K |
|
1100
iShares Core S&P 500 ETF
IVV
$908B
| $10.1M | ﹤0.01% |
16,341
-20,678
| -56% | -$11.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.